skip to content
Competitive problems in the drug industry : hearings before the Subcommittee on Monopoly of the Select Committee on Small Business, United States Senate, Ninetieth Congress, first session on present status of competition in the pharmaceutical industry ... Preview this item
ClosePreview this item
Checking...

Competitive problems in the drug industry : hearings before the Subcommittee on Monopoly of the Select Committee on Small Business, United States Senate, Ninetieth Congress, first session on present status of competition in the pharmaceutical industry ...

Author: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly.
Publisher: Washington, DC : United States Government Printing Office, 1967-1979.
Edition/Format:   Print book : National government publication : EnglishView all editions and formats
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Additional Physical Format: Online version:
United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly.
Competitive problems in the drug industry.
Washington : U.S. Govt. Print. Off., 1967-
(OCoLC)654114458
Material Type: Government publication, National government publication
Document Type: Book
All Authors / Contributors: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly.
OCLC Number: 1849797
Notes: Hearings held May 15, 1967-
"Parts 1-6 have no additional titles."
Description: 34 volumes (17092 pages) : illustrations ; 23 cm
Contents: pt. 7 --
first of two volumes on Indomethacin trade name: Indocin --
pt. 8 --
second of two volumes on Indomethacin trade name: Indocin --
pt. 12 --
Drug combinations-antibiotics --
pt. 13 --
Psychotropic drugs --
pt. 14 --
Medical students-AMA-FDA (drug testing) --
pt. 15 --
Oral contraceptives (volume one) --
pt. 16 --
Oral contraceptives (volume two) --
pt. 17 Oral contraceptives (volume three) appendixes --
pt. 18 --
Government procurement (Vol. 1) --
pt. 19 --
Government procurement (Vol. 2) --
pt. 20 --
Government procurement (Vol. 3) --
pt. 21 --
Government procurement (Vol. 4) appendixes --
pt. 22 --
Government procurement (Vol. 5) --
pt. 23 --
Development and marketing of prescription drugs --
pt. 24 --
Government procurement (Vol. 6) --
pt. 25 --
Oral hypoglycemic drugs --
pt. 26 --
Government procurement (Vol. 7) --
pt. 27 --
Safety, efficacy, and use of antibiotics-clindamycin and lincomycin --
pt. 28 --
Oral hypoglycemic drugs (continued) --
pt. 29 --
Government procurement (Vol. 8) (bioequivalence and bioavailability) --
pt. 30 --
Pharmaceutical industry and medical education (Vol. 1) --
pt. 31 --
Safety and efficacy of anti-obesity drugs --
pt. 32 --
Pharmaceutical company practices in labeling and promoting prescription drugs sold in Latin America --
pt. 33 --
Drug quality, competition, and government procurement of drugs --
pt. 34 Safety, efficacy, and usefulness of Darvon and other preparations containing propoxyphene.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


\n\n

Primary Entity<\/h3>\n
<http:\/\/www.worldcat.org\/oclc\/1849797<\/a>> # Competitive problems in the drug industry : hearings before the Subcommittee on Monopoly of the Select Committee on Small Business, United States Senate, Ninetieth Congress, first session on present status of competition in the pharmaceutical industry ...<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Book<\/a>, schema:CreativeWork<\/a> ;\u00A0\u00A0\u00A0\nlibrary:oclcnum<\/a> \"1849797<\/span>\" ;\u00A0\u00A0\u00A0\nlibrary:placeOfPublication<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Place\/washington_dc<\/a>> ; # Washington, DC<\/span>\n\u00A0\u00A0\u00A0\nlibrary:placeOfPublication<\/a> <http:\/\/id.loc.gov\/vocabulary\/countries\/dcu<\/a>> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/oral_medication<\/a>> ; # Oral medication<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/industrie_pharmaceutique_etats_unis<\/a>> ; # Industrie pharmaceutique--\u00C9tats-Unis<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Place\/united_states<\/a>> ; # United States<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/drug_industry<\/a>> ; # Drug Industry<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/costs_and_cost_analysis<\/a>> ; # Costs and Cost Analysis<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/drugs<\/a>> ; # Drugs<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/medicaments_marketing<\/a>> ; # M\u00E9dicaments--Marketing<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/pharmaceutical_industry<\/a>> ; # Pharmaceutical industry<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/id.loc.gov\/authorities\/subjects\/sh2008108871<\/a>> ; # Pharmaceutical industry--United States<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/economics<\/a>> ; # Economics<\/span>\n\u00A0\u00A0\u00A0\nschema:bookFormat<\/a> bgn:PrintBook<\/a> ;\u00A0\u00A0\u00A0\nschema:creator<\/a> <http:\/\/viaf.org\/viaf\/146659214<\/a>> ; # United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly.<\/span>\n\u00A0\u00A0\u00A0\nschema:datePublished<\/a> \"1967\/1979<\/span>\" ;\u00A0\u00A0\u00A0\nschema:description<\/a> \"pt. 7 -- first of two volumes on Indomethacin trade name: Indocin -- pt. 8 -- second of two volumes on Indomethacin trade name: Indocin -- pt. 12 -- Drug combinations-antibiotics -- pt. 13 -- Psychotropic drugs -- pt. 14 -- Medical students-AMA-FDA (drug testing) -- pt. 15 -- Oral contraceptives (volume one) -- pt. 16 -- Oral contraceptives (volume two) -- pt. 17 Oral contraceptives (volume three) appendixes -- pt. 18 -- Government procurement (Vol. 1) -- pt. 19 -- Government procurement (Vol. 2) -- pt. 20 -- Government procurement (Vol. 3) -- pt. 21 -- Government procurement (Vol. 4) appendixes -- pt. 22 -- Government procurement (Vol. 5) -- pt. 23 -- Development and marketing of prescription drugs -- pt. 24 -- Government procurement (Vol. 6) -- pt. 25 -- Oral hypoglycemic drugs -- pt. 26 -- Government procurement (Vol. 7) -- pt. 27 -- Safety, efficacy, and use of antibiotics-clindamycin and lincomycin -- pt. 28 -- Oral hypoglycemic drugs (continued) -- pt. 29 -- Government procurement (Vol. 8) (bioequivalence and bioavailability) -- pt. 30 -- Pharmaceutical industry and medical education (Vol. 1) -- pt. 31 -- Safety and efficacy of anti-obesity drugs -- pt. 32 -- Pharmaceutical company practices in labeling and promoting prescription drugs sold in Latin America -- pt. 33 -- Drug quality, competition, and government procurement of drugs -- pt. 34 Safety, efficacy, and usefulness of Darvon and other preparations containing propoxyphene.<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:exampleOfWork<\/a> <http:\/\/worldcat.org\/entity\/work\/id\/3861834932<\/a>> ;\u00A0\u00A0\u00A0\nschema:genre<\/a> \"Government publication<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:genre<\/a> \"National government publication<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:inLanguage<\/a> \"en<\/span>\" ;\u00A0\u00A0\u00A0\nschema:isSimilarTo<\/a> <http:\/\/www.worldcat.org\/oclc\/654114458<\/a>> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Competitive problems in the drug industry : hearings before the Subcommittee on Monopoly of the Select Committee on Small Business, United States Senate, Ninetieth Congress, first session on present status of competition in the pharmaceutical industry ...<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:productID<\/a> \"1849797<\/span>\" ;\u00A0\u00A0\u00A0\nschema:publication<\/a> <http:\/\/www.worldcat.org\/title\/-\/oclc\/1849797#PublicationEvent\/washington_dc_united_states_government_printing_office_1967_1979<\/a>> ;\u00A0\u00A0\u00A0\nschema:publisher<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Agent\/united_states_government_printing_office<\/a>> ; # United States Government Printing Office<\/span>\n\u00A0\u00A0\u00A0\nwdrs:describedby<\/a> <http:\/\/www.worldcat.org\/title\/-\/oclc\/1849797<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Related Entities<\/h3>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Agent\/united_states_government_printing_office<\/a>> # United States Government Printing Office<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:Agent<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"United States Government Printing Office<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Place\/united_states<\/a>> # United States<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Place<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"United States<\/span>\" ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"United States.<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Place\/washington_dc<\/a>> # Washington, DC<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Place<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Washington, DC<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/costs_and_cost_analysis<\/a>> # Costs and Cost Analysis<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Costs and Cost Analysis<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/drug_industry<\/a>> # Drug Industry<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Drug Industry<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/drugs<\/a>> # Drugs<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Drugs<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/economics<\/a>> # Economics<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Economics<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/industrie_pharmaceutique_etats_unis<\/a>> # Industrie pharmaceutique--\u00C9tats-Unis<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Industrie pharmaceutique--\u00C9tats-Unis<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/medicaments_marketing<\/a>> # M\u00E9dicaments--Marketing<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"M\u00E9dicaments--Marketing<\/span>\"@fr<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/oral_medication<\/a>> # Oral medication<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Oral medication<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Topic\/pharmaceutical_industry<\/a>> # Pharmaceutical industry<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Pharmaceutical industry<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/id.loc.gov\/authorities\/subjects\/sh2008108871<\/a>> # Pharmaceutical industry--United States<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Pharmaceutical industry--United States<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/id.loc.gov\/vocabulary\/countries\/dcu<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:Place<\/a> ;\u00A0\u00A0\u00A0\ndcterms:identifier<\/a> \"dcu<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/viaf.org\/viaf\/146659214<\/a>> # United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly.<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Organization<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly.<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/www.worldcat.org\/oclc\/654114458<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:CreativeWork<\/a> ;\u00A0\u00A0\u00A0\nrdfs:label<\/a> \"Competitive problems in the drug industry.<\/span>\" ;\u00A0\u00A0\u00A0\nschema:description<\/a> \"Online version:<\/span>\" ;\u00A0\u00A0\u00A0\nschema:isSimilarTo<\/a> <http:\/\/www.worldcat.org\/oclc\/1849797<\/a>> ; # Competitive problems in the drug industry : hearings before the Subcommittee on Monopoly of the Select Committee on Small Business, United States Senate, Ninetieth Congress, first session on present status of competition in the pharmaceutical industry ...<\/span>\n\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/www.worldcat.org\/title\/-\/oclc\/1849797<\/a>>\u00A0\u00A0\u00A0\u00A0a \ngenont:InformationResource<\/a>, genont:ContentTypeGenericResource<\/a> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/www.worldcat.org\/oclc\/1849797<\/a>> ; # Competitive problems in the drug industry : hearings before the Subcommittee on Monopoly of the Select Committee on Small Business, United States Senate, Ninetieth Congress, first session on present status of competition in the pharmaceutical industry ...<\/span>\n\u00A0\u00A0\u00A0\nschema:dateModified<\/a> \"2020-07-04<\/span>\" ;\u00A0\u00A0\u00A0\nvoid:inDataset<\/a> <http:\/\/purl.oclc.org\/dataset\/WorldCat<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/www.worldcat.org\/title\/-\/oclc\/1849797#PublicationEvent\/washington_dc_united_states_government_printing_office_1967_1979<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:PublicationEvent<\/a> ;\u00A0\u00A0\u00A0\nschema:location<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Place\/washington_dc<\/a>> ; # Washington, DC<\/span>\n\u00A0\u00A0\u00A0\nschema:organizer<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/3861834932#Agent\/united_states_government_printing_office<\/a>> ; # United States Government Printing Office<\/span>\n\u00A0\u00A0\u00A0\nschema:startDate<\/a> \"1967-1979<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Content-negotiable representations<\/p>\n